• Science Saturday: A new understanding of the inner workings of CAR-T cell therapy

a medical illustration of CAR-T cell therapy for cancer

Mayo Clinic researchers have biomanufactured chimeric antigen receptor-T cell therapy  (CAR-T cell therapy) in a new way to track the cells' cancer-fighting journey and predict toxic side effects. This Mayo Clinic breakthrough, published in Cancer Immunology Research, also could unravel the mystery of how to unleash CAR-T cell therapy to destroy solid tumors.

"This new technology allows us to image CAR-T cells after they are given to patients and study their fate," says Saad Kenderian, M.B., Ch.B., a Mayo Clinic hematologist and researcher, and lead author. "This allows us to investigate strategies that could improve CAR-T cell trafficking and penetration into the tumor cells, and thus can improve tumor killing."

The research

Mayo Clinic researchers engineered CAR-T cells to express a sodium iodide symporter protein that could be imaged by a positron emission tomography (PET) scan in preclinical models. Investigators monitored in real-time, tracking precisely how CAR-T cells multiplied and targeted cancer for destruction. This new imaging lays the foundation for strategies that could use CAR-T cell therapy to fight more types of disease.

"Until now, we have not had a clinically relevant imaging platform to monitor cell expansion and trafficking to tumor sites," says Dr. Kenderian. "We can show in mouse models that imaging by PET scans shows how CAR-T cells move, and when they increase in number and cause side effects. This new understanding may help us expand CAR-T cell therapy to more cancers so more patients can benefit."

A new type of regenerative immunotherapy

Immunotherapies unlock the body’s defense mechanisms to fight bacteria, viruses and diseases, including cancer. CAR-T cell therapy is a new type of regenerative immunotherapy that harnesses the body's defense system by genetically modifying cells, equipping them to go on search-and-destroy missions to kill cancer. These synthetic cells become a living drug that mobilizes through the body, continually tapping the immune system to attack disease.

Read the rest of the article on the Center for Regenerative Medicine blog.


Other Mayo Clinic medical research websites:

Related articles